Two novel peptides derived from Protagonist's proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application submissions to the FDA potentially in ...

Gilead’s an­ti­body-drug con­ju­gate Trodelvy com­bined with Mer­ck’s Keytru­da re­duced the risk of dis­ease pro­gres­sion or death in a key study of an ag­gres­sive form of … ...

The year 2025 is witnessing a significant expansion of the Medical Info Systems industry, fueled by new federal policies and strong regulatory support. A major catalyst is Donald Trump's $500 ...

The phase 3 study plans to enroll 25 patients, with final completion anticipated in September 2029. Treatment with nadofaragene led to a complete response rate of 75% at 3 months. Nadofaragene ...

Additionally, a phase 3 trial evaluating the combination is planned, pending feedback from an FDA end-of-phase 2 meeting. “This is one of the strongest data set ever seen in an all-comer population of ...

Mark Huffman has been a consumer news reporter for ConsumerAffairs since 2004. He covers real estate, gas prices and the economy and has reported extensively on negative-option sales. He was ...

Emerge is the third Phase 3 study of MM120 ODT, with the Voyage and Panorama studies in GAD already underway. “In our Phase 2b study, MADRS score improvements after a single MM120 100 µg dose ...

PRINCETON, N.J., April 14, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients ...

A MAJOR charity retailer has abruptly shut three branches with 47 more set to close as part of a major overhaul. Scope, which runs branches across England and Wales, has shuttered the three stores ...

Ironwood Pharmaceuticals shares sank after the company said it needs to conduct a confirmatory phase 3 trial of proposed short-bowel treatment apraglutide. The stock hit a 52-week low in mid ...